List of Figures:
Figure 3-1: Global - Vaccine Market (Billion US$), 2010-2013
Figure 4-1: Global - Vaccine R&D Investment by Region (%), 2010
Figure 5-1: Global - Key M&As in Vaccine Market (2005-2010)
Figure 6-1: Global - Causes of Deaths in Children (<5 Years) among Low-income Countries (%), 2011
Figure 6-2: Global - Pneumococcal Vaccine Market (Billion US$), 2010-2013
Figure 6-3: Global - Number of Polio Incidences (2007-2010)
Figure 6-4: Global - Polio Vaccine Market (Billion US$), 2010-2013
Figure 6-5: Global - Varicella Vaccine Market (Billion US$), 2010-2013
Figure 6-6: Global - Meningococcal Vaccine Market (Million US$), 2010-2013
Figure 6-7: Global - Rotavirus Vaccine Market (Million US$), 2010-2013
Figure 6-8: Global - Rotavirus Vaccine Market by Region (%), 2010
Figure 6-9: Global - Number of Diphtheria Incidences by Region (2009 & 2010)
Figure 6-10: Global - Number of Ntetanus Incidences by Region (2009 & 2010)
Figure 6-11: Global - Number of Ttetanus Incidences by Region (2009 & 2010)
Figure 6-12: Global - Number of Pertussis Incidences by Region (2009 & 2010)
Figure 6-13: Global - Number of Measles Incidences by Region (2009 & 2010)
Figure 6-14: Global - Number of Mumps Incidences by Region (‘000), 2009 & 2010
Figure 6-15: Global - Number of Rubella Incidences by Region (2009 & 2010)
Figure 6-16: Global - Number of Tuberculosis Incidences by Region (2008 & 2009)
Figure 7-1: Global - Hepatitis B Surface Antigen Prevalence (%)
Figure 7-2: Global - Hepatitis B Vaccine Market (Billion US$), 2010-2013
Figure 7-3: Global - Malaria Vaccines under Pipeline
Figure 7-4: Global - Yellow Fever Vaccine Market (Million US$), 2010 & 2013
Figure 7-5: Global - Japanese Encephalitis Market (Million US$), 2010-2013
Figure 7-6: Global - R&D Investment in AIDS Vaccine Development (Million US$), 2006-2009
Figure 7-7: Global - Sources for Funding in HIV Vaccine R&D (%), 2009
Figure 7-8: Global - Cancer Vaccine Market (Billion US$), 2010-2013
Figure 7-9: Global - Seasonal Influenza Vaccine Market (Billion US$), 2010-2013
Figure 8-1: Global - Vaccine Market by Region (%), 2010
Figure 8-2: Global - Forecast for Vaccine Market by Region (%), 2013
Figure 8-3: US - Vaccine Market (Billion US$), 2010-2013
Figure 8-4: US - Share of Key Players in Vaccine Market (2010)
Figure 8-5: US - Pediatric Vaccine Market (Billion US$), 2010-2013
Figure 8-6: US - Adult Vaccine Market (Billion US$), 2010-2013
Figure 8-7: US - Hepatitis Vaccine Market (Billion US$), 2010-2013
Figure 8-8: US - Share of Key Players in Seasonal Influenza Vaccine Production (2010-2011)
Figure 8-9: US - Seasonal Influenza Vaccine Production and Consumption (Million Doses), 2006-07 to 2010-11
Figure 8-10: US - Seasonal Influenza Vaccine Market (Billion US$), 2010-2013
Figure 8-11: Europe - Vaccine Market (Billion US$), 2010-2013
Figure 8-12: Europe - Share of Key Players in Vaccine Market (2008)
Figure 8-13: China - Vaccine Market (Billion RMB), 2010-2013
Figure 8-14: China - Share of Key Players in Vaccine Market (2008)
Figure 8-15: China - Influenza Vaccine Market (Million US$), 2010-2013
Figure 8-16: India - Share of Domestic Consumption and Exports in Vaccine Market (2010)
Figure 8-17: India - Vaccine Market (Million US$), 2010-2013
Figure 8-18: India - Share of Key Players in Vaccine Market (2010)
Figure 8-19: Japan - Vaccine Market (Billion US$), 2010-2013
Figure 8-20: Japan - Seasonal Influenza Vaccine Market (Million US$), 2010-2013
Figure 8-21: Japan - Share of Domestic and Foreign Players in Vaccine Market (2009)
Figure 8-22: Brazil - Vaccine Market (Billion BRL), 2010-2013
Figure 8-23: Brazil - Share of Public and Private Sector in Vaccine Market
Figure 8-24: Brazil - Share of Key Players in Private Sector Vaccine Market (2008)
Figure 9-1: Global - Dose Consumption and Revenue by Regional Income (%)
Figure 10-1: Global - Share of Key Players in Vaccine Market (2009)
List of Tables:
Table 3-1: Global - Production Method for Key Vaccines
Table 4-1: Global - Key Health Indicators by Income Classification
Table 5-1: Global - Recent Deals between Key Western Vaccine Manufacturers and Companies in Emerging Markets
Table 5-2: Global - Key Intradermal Delivery Devices
Table 6-1: Global - Leading DTP Vaccine Brands (Million US$), 2008
Table 6-2: Global - Leading MMR Vaccine Brands (Million US$), 2008
Table 6-3: Global - Tuberculosis Vaccines under Pipeline (2010)
Table 7-1: Global - Number of HIV/AIDS Patients by Region (2009)
Table 7-2: Global - HIV Vaccines under Pipeline
Table 7-3: Global - Cancer Statistics in More Developed and Less Developed Regions (2008)
Table 7-4: Global - Cancer Vaccines under Pipeline (2009)
Table 7-5: Global - Top 5 Companies’ Pandemic Influenza (H1N1) Vaccine Sales (Million US$), 2009
Table 8-1: China - Number of Reported Cases of Diseases Preventable by Vaccine (2008 & 2009)
Table 8-2: China - Vaccine Classification
Table 8-3: China - Annual Pediatric Vaccine Doses Requirement (Million Doses)
Table 8-4: Japan - Sales of Top Domestic Vaccine Manufacturers (Million JPY)
Table 9-1: Health Statistics in Developed and Developing Countries (%)
Table 10-1: Sanofi Aventis - Strengths and Weaknesses
Table 10-2: Novartis - Strengths and Weaknesses
Table 10-3: GSK - Strengths and Weaknesses
Table 10-4: Pfizer - Strengths and Weaknesses
